Scale Down for Endometrial Cancer

NCT03169023 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 155

Last updated 2019-02-28

No results posted yet for this study

Summary

This proposal will pilot a weight management program for patients with endometrial cancer, the cancer most associated with obesity. If successful, this pilot could be expanded to include obese women with other gynecologic cancers (ovarian and cervical) and could be expanded and adapted for use not only upon completion of treatment, but during chemotherapy or radiation. Furthermore, other obstetricians and gynecologists could use this strategy for obese women as a practical cancer prevention strategy for obesity-associated cancers.

Conditions

Interventions

BEHAVIORAL

ScaleDown

-Participants receives behavioral prompts and daily feedback by text messaging with motivational instructions for specific dietary and behavior modifications

BEHAVIORAL

Enhanced Usual Care Packets

-From the American Cancer Society Website

OTHER

12-Item Short Form Health Survey

-Measures functional health and well-being from the patient's perspective

OTHER

International Physical Activity Questionnaire short form

-7 item scale that measures a range of physical activity from vigorous to sedentary over the last 7 days

OTHER

Multidimensional Body Self Relations Questionnaire - Appearance Subscales

-Gold-standard for the assessment of body image attitudes and contains 34 items

OTHER

Cancer-Related Body Image Scale

-13 item scale adapted from The Breast - impact of Treatment Scale, which assesses survivors' intrusive thoughts and avoidant behaviors with respect to their bodies since cancer treatment

OTHER

Patient Health Questionnaire 9-Item Version

-Widely used measure that assesses mood, including an item that screens for suicidality

BEHAVIORAL

iOTA

-Washington University based intervention

Sponsors & Collaborators

  • ScaleDown

    collaborator UNKNOWN
  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Andrea Hagemann, M.D. · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-21
Primary Completion
2019-02-03
Completion
2019-02-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03169023 on ClinicalTrials.gov